GT Medical Technologies Recognizes Saint Luke's Hospital as a GammaTile Center of Excellence
In recent developments within the medical field, GT Medical Technologies proudly announced that Saint Luke's Hospital in Kansas City has been awarded the designation as a GammaTile® Center of Excellence.
This prestigious recognition is reserved for healthcare institutions that exhibit remarkable proficiency in the GammaTile procedure, a state-of-the-art approach designed specifically for the treatment of brain tumors. The GammaTile technique involves advanced radiation therapy that is applied during the surgical removal of tumors. By administering localized radiation immediately post-surgery, this innovative method stands out as it targets residual cancer cells at their most vulnerable stage, therefore aiming to enhance treatment efficacy and decrease the chances of recurrence.
The selection criteria for this honor involve not only an assessment of clinical expertise but also a requirement for physicians to meet annual case minimums and pursue ongoing education in the field. Among those recognized are distinguished neurosurgeons Jonathan Breshears, MD, and Tarek El Ahmadieh, MD, alongside radiation oncologists Susan Herzberg, MD, and Sunpreet Rakhra, MD, who have all demonstrated exceptional capabilities in utilizing the GammaTile procedure.
GammaTile is unique in that it is a bioabsorbable collagen implant that features radiation seeds and is inserted directly into the cavity post-tumor removal. Traditional methods of treatment often experience a delay from surgery to the initiation of radiation therapy due to the need for the surgical site to heal. By contrast, GammaTile’s innovative mechanism allows for immediate localized radiation, thus maximizing the likelihood of effectively combatting any remaining cancer cells while minimizing unwanted exposure to healthy tissue.
GT Medical Technologies was founded by a committed team of experts in the brain tumor specialty field, striving to meet the unmet needs of patients. Their unwavering goal is to elevate the standard of care for individuals affected by brain tumors through innovative treatments like GammaTile. Despite being launched commercially in March 2020, the usage of GammaTile has expanded rapidly, now being implemented at over 100 leading medical centers across the United States. This growth speaks to the medical community's increasing confidence in the GammaTile method as a vital tool in treating brain tumors.
As patient care advances, the recognition of leading institutions like Saint Luke's Hospital through GammaTile Center of Excellence emphasizes the importance of innovative treatments in enhancing the longevity and quality of life for patients undergoing brain tumor therapies. GT Medical Technologies continues its vital mission to improve treatment outcomes through pioneering solutions and commitment to healthcare excellence.
For those seeking further information about GammaTile and its implementation, GT Medical Technologies has made details accessible at gammatile.com. Followers can also remain connected via social media platforms like Facebook, Instagram, LinkedIn, and X to explore ongoing developments and updates in patient care.
This announcement underlines the significance of continual advancement in medical practices and the dedication needed to improve patient outcomes in the challenging domain of brain tumor treatment. With GammaTile now recognized as an essential option for brain tumor therapy, the future looks promising for improved patient care methods rooted in innovation and specialization.
This prestigious recognition is reserved for healthcare institutions that exhibit remarkable proficiency in the GammaTile procedure, a state-of-the-art approach designed specifically for the treatment of brain tumors. The GammaTile technique involves advanced radiation therapy that is applied during the surgical removal of tumors. By administering localized radiation immediately post-surgery, this innovative method stands out as it targets residual cancer cells at their most vulnerable stage, therefore aiming to enhance treatment efficacy and decrease the chances of recurrence.
The selection criteria for this honor involve not only an assessment of clinical expertise but also a requirement for physicians to meet annual case minimums and pursue ongoing education in the field. Among those recognized are distinguished neurosurgeons Jonathan Breshears, MD, and Tarek El Ahmadieh, MD, alongside radiation oncologists Susan Herzberg, MD, and Sunpreet Rakhra, MD, who have all demonstrated exceptional capabilities in utilizing the GammaTile procedure.
GammaTile is unique in that it is a bioabsorbable collagen implant that features radiation seeds and is inserted directly into the cavity post-tumor removal. Traditional methods of treatment often experience a delay from surgery to the initiation of radiation therapy due to the need for the surgical site to heal. By contrast, GammaTile’s innovative mechanism allows for immediate localized radiation, thus maximizing the likelihood of effectively combatting any remaining cancer cells while minimizing unwanted exposure to healthy tissue.
GT Medical Technologies was founded by a committed team of experts in the brain tumor specialty field, striving to meet the unmet needs of patients. Their unwavering goal is to elevate the standard of care for individuals affected by brain tumors through innovative treatments like GammaTile. Despite being launched commercially in March 2020, the usage of GammaTile has expanded rapidly, now being implemented at over 100 leading medical centers across the United States. This growth speaks to the medical community's increasing confidence in the GammaTile method as a vital tool in treating brain tumors.
As patient care advances, the recognition of leading institutions like Saint Luke's Hospital through GammaTile Center of Excellence emphasizes the importance of innovative treatments in enhancing the longevity and quality of life for patients undergoing brain tumor therapies. GT Medical Technologies continues its vital mission to improve treatment outcomes through pioneering solutions and commitment to healthcare excellence.
For those seeking further information about GammaTile and its implementation, GT Medical Technologies has made details accessible at gammatile.com. Followers can also remain connected via social media platforms like Facebook, Instagram, LinkedIn, and X to explore ongoing developments and updates in patient care.
This announcement underlines the significance of continual advancement in medical practices and the dedication needed to improve patient outcomes in the challenging domain of brain tumor treatment. With GammaTile now recognized as an essential option for brain tumor therapy, the future looks promising for improved patient care methods rooted in innovation and specialization.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.